Birdwatch Note
2025-01-04 03:43:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The claims about the effectiveness of this cancer treatment schedule are unsubstantiated and not enough data has been collected. Clinical trials can take over ten years in some cases before a drug is approved for treatment to the general population. https://science.feedback.org/review/lack-evidence-cancer-treatment-protocol-recommends-antiparasitic-drugs-ivermectin-mebendazole/ https://www.healthline.com/health/pancreatic-cancer/fenbendazole-for-pancreatic-cancer#what-research-shows https://infiuss.com/insights/how-long-do-clinical-trials-take https://www.antidote.me/blog/how-long-do-clinical-trial-phases-take
Written by 6E13142A81A6F2ACBFF976EE9F3E7B353AA49C2A26E98E6F9AB678CCB7BEFE10
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1875265828842590279
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1875387540171034918
- noteId - 1875387540171034918
- participantId -
- noteAuthorParticipantId - 6E13142A81A6F2ACBFF976EE9F3E7B353AA49C2A26E98E6F9AB678CCB7BEFE10 Participant Details
- createdAtMillis - 1735962207249
- tweetId - 1875265828842590279
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The claims about the effectiveness of this cancer treatment schedule are unsubstantiated and not enough data has been collected. Clinical trials can take over ten years in some cases before a drug is approved for treatment to the general population. https://science.feedback.org/review/lack-evidence-cancer-treatment-protocol-recommends-antiparasitic-drugs-ivermectin-mebendazole/ https://www.healthline.com/health/pancreatic-cancer/fenbendazole-for-pancreatic-cancer#what-research-shows https://infiuss.com/insights/how-long-do-clinical-trials-take https://www.antidote.me/blog/how-long-do-clinical-trial-phases-take
Note Ratings
| rated at | rated by | |
| 2025-01-04 13:46:56 -0600 | Rating Details | |
| 2025-01-04 13:20:21 -0600 | Rating Details | |
| 2025-01-04 11:58:44 -0600 | Rating Details | |
| 2025-01-04 09:33:57 -0600 | Rating Details | |
| 2025-01-04 08:44:01 -0600 | Rating Details | |
| 2025-01-04 07:40:42 -0600 | Rating Details | |
| 2025-01-04 05:18:11 -0600 | Rating Details | |
| 2025-01-04 04:29:02 -0600 | Rating Details | |
| 2025-01-04 04:16:42 -0600 | Rating Details | |
| 2025-01-04 04:13:18 -0600 | Rating Details | |
| 2025-01-04 04:04:52 -0600 | Rating Details | |
| 2025-01-04 03:56:10 -0600 | Rating Details | |
| 2025-01-04 03:42:00 -0600 | Rating Details | |
| 2025-01-04 03:36:02 -0600 | Rating Details | |
| 2025-01-04 03:10:05 -0600 | Rating Details | |
| 2025-01-04 00:35:30 -0600 | Rating Details | |
| 2025-01-04 00:32:16 -0600 | Rating Details | |
| 2025-01-03 23:33:41 -0600 | Rating Details | |
| 2025-01-03 22:00:21 -0600 | Rating Details | |
| 2025-01-05 18:11:31 -0600 | Rating Details | |
| 2025-01-05 12:19:13 -0600 | Rating Details | |
| 2025-01-05 10:34:37 -0600 | Rating Details | |
| 2025-01-05 06:31:54 -0600 | Rating Details | |
| 2025-01-05 06:23:39 -0600 | Rating Details | |
| 2025-01-05 05:42:43 -0600 | Rating Details | |
| 2025-01-05 03:55:27 -0600 | Rating Details | |
| 2025-01-05 03:38:09 -0600 | Rating Details | |
| 2025-01-05 02:30:29 -0600 | Rating Details | |
| 2025-01-05 02:27:13 -0600 | Rating Details | |
| 2025-01-05 02:12:06 -0600 | Rating Details | |
| 2025-01-05 00:33:42 -0600 | Rating Details | |
| 2025-01-04 22:31:03 -0600 | Rating Details | |
| 2025-01-04 22:17:14 -0600 | Rating Details | |
| 2025-01-04 21:13:33 -0600 | Rating Details | |
| 2025-01-04 20:54:07 -0600 | Rating Details | |
| 2025-01-04 20:52:25 -0600 | Rating Details | |
| 2025-01-04 20:22:31 -0600 | Rating Details | |
| 2025-01-04 20:04:18 -0600 | Rating Details | |
| 2025-01-04 19:46:01 -0600 | Rating Details | |
| 2025-01-04 19:18:05 -0600 | Rating Details | |
| 2025-01-04 18:23:39 -0600 | Rating Details | |
| 2025-01-04 18:14:55 -0600 | Rating Details | |
| 2025-01-04 18:13:23 -0600 | Rating Details | |
| 2025-01-04 16:28:46 -0600 | Rating Details | |
| 2025-01-04 16:07:13 -0600 | Rating Details | |
| 2025-01-04 15:32:15 -0600 | Rating Details | |
| 2025-01-04 15:27:36 -0600 | Rating Details | |
| 2025-01-04 13:28:21 -0600 | Rating Details | |
| 2025-01-04 12:21:50 -0600 | Rating Details | |
| 2025-01-04 12:05:20 -0600 | Rating Details | |
| 2025-01-04 10:41:05 -0600 | Rating Details | |
| 2025-01-04 10:32:24 -0600 | Rating Details | |
| 2025-01-04 09:33:23 -0600 | Rating Details | |
| 2025-01-04 07:01:44 -0600 | Rating Details | |
| 2025-01-04 05:14:15 -0600 | Rating Details | |
| 2025-01-04 04:46:15 -0600 | Rating Details | |
| 2025-01-04 02:10:53 -0600 | Rating Details | |
| 2025-01-04 01:18:19 -0600 | Rating Details | |
| 2025-01-04 00:53:48 -0600 | Rating Details | |
| 2025-01-04 00:24:48 -0600 | Rating Details | |
| 2025-01-03 23:02:46 -0600 | Rating Details | |
| 2025-01-03 22:56:29 -0600 | Rating Details | |
| 2025-01-05 12:30:12 -0600 | Rating Details | |
| 2025-01-05 11:26:48 -0600 | Rating Details | |
| 2025-01-05 08:10:30 -0600 | Rating Details | |
| 2025-01-05 07:50:04 -0600 | Rating Details | |
| 2025-01-05 02:52:53 -0600 | Rating Details | |
| 2025-01-05 01:19:31 -0600 | Rating Details | |
| 2025-01-05 00:30:02 -0600 | Rating Details | |
| 2025-01-04 23:00:59 -0600 | Rating Details | |
| 2025-01-04 19:35:39 -0600 | Rating Details | |
| 2025-01-04 19:35:38 -0600 | Rating Details | |
| 2025-01-04 18:49:25 -0600 | Rating Details | |
| 2025-01-04 18:26:18 -0600 | Rating Details | |
| 2025-01-04 16:02:09 -0600 | Rating Details | |
| 2025-01-04 15:01:26 -0600 | Rating Details | |
| 2025-01-04 14:20:11 -0600 | Rating Details | |
| 2025-01-04 14:16:05 -0600 | Rating Details | |
| 2025-01-04 12:58:15 -0600 | Rating Details | |
| 2025-01-04 10:47:46 -0600 | Rating Details | |
| 2025-01-04 10:14:14 -0600 | Rating Details | |
| 2025-01-04 09:51:34 -0600 | Rating Details | |
| 2025-01-04 09:46:39 -0600 | Rating Details | |
| 2025-01-04 09:25:12 -0600 | Rating Details | |
| 2025-01-04 09:24:19 -0600 | Rating Details | |
| 2025-01-04 08:33:23 -0600 | Rating Details | |
| 2025-01-04 06:59:21 -0600 | Rating Details | |
| 2025-01-04 06:57:56 -0600 | Rating Details | |
| 2025-01-04 05:43:33 -0600 | Rating Details | |
| 2025-01-04 05:31:42 -0600 | Rating Details | |
| 2025-01-04 03:21:40 -0600 | Rating Details | |
| 2025-01-04 02:22:22 -0600 | Rating Details | |
| 2025-01-04 01:50:09 -0600 | Rating Details | |
| 2025-01-04 01:39:56 -0600 | Rating Details | |
| 2025-01-04 01:28:51 -0600 | Rating Details | |
| 2025-01-04 01:24:05 -0600 | Rating Details | |
| 2025-01-04 00:46:16 -0600 | Rating Details | |
| 2025-01-04 00:04:43 -0600 | Rating Details |